Use of continuous subcutaneous insulin infusion in children and adolescents with type 1 diabetes mellitus: a systematic mapping review
Abstract Background Among the treatments for type 1 diabetes mellitus (T1DM), Continuous Subcutaneous Insulin Infusion (CSII) is a device that infuses insulin through the subcutaneous tissue in an uninterrupted manner and that comes closest to the physiological secretion of insulin. The use of CSII...
Main Authors: | Carolina Spinelli Alvarenga, Rebecca Ortiz La Banca, Rhyquelle Rhibna Neris, Valéria de Cássia Sparapani, Miguel Fuentealba-Torres, Denisse Cartagena-Ramos, Camila Lima Leal, Marcos Venicio Esper, Lucila Castanheira Nascimento |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2022-02-01
|
Series: | BMC Endocrine Disorders |
Subjects: | |
Online Access: | https://doi.org/10.1186/s12902-022-00950-7 |
Similar Items
-
Crianças em seguimento ambulatorial: perspectivas do atendimento evidenciadas por entrevista com fantoche
by: Ana Carolina Andrade Biaggi Leite, et al.
Published: (2019-02-01) -
Comparative study of the adverse effects of subcutaneous and intraveneous infusion in patients admitted to neurology ward
by: Simin Jahani, et al.
Published: (2009-10-01) -
Continuous subcutaneous insulin infusion versus multiple dose insulin
by: Yashdeep Gupta, et al.
Published: (2014-08-01) -
An evaluation of continuous subcutaneous infusions across seven NHS acute hospitals: is there potential for 48-hour infusions?
by: J. Baker, et al.
Published: (2020-07-01) -
Continuous subcutaneous insulin infusion therapy: effects on quality of life
by: U Scheidegger, et al.
Published: (2007-08-01)